Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163290 | SCV000213818 | benign | Hereditary cancer-predisposing syndrome | 2015-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000189900 | SCV000243558 | benign | not specified | 2017-09-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000205984 | SCV000261806 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000350114 | SCV000395599 | likely benign | Tuberous sclerosis syndrome | 2018-09-12 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Athena Diagnostics | RCV000189900 | SCV001476297 | benign | not specified | 2020-06-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000205984 | SCV002041424 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163290 | SCV002531028 | benign | Hereditary cancer-predisposing syndrome | 2020-12-26 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000189900 | SCV002774069 | benign | not specified | 2020-06-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001572810 | SCV004010422 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BS1, BS2 |
KCCC/NGS Laboratory, |
RCV000205984 | SCV004016177 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000205984 | SCV004360875 | benign | Tuberous sclerosis 2 | 2022-08-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000189900 | SCV004813663 | likely benign | not specified | 2024-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004528906 | SCV000305165 | benign | TSC2-related disorder | 2019-05-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV001572810 | SCV001797758 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001572810 | SCV001925892 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572810 | SCV001975407 | likely benign | not provided | no assertion criteria provided | clinical testing |